Ranitidine (RAN) is among the drugs connected with idiosyncratic adverse drug reactions (IADRs) in human being individuals. Furthermore, a PAI-1 inhibitor decreased neutrophil activation and liver organ damage after LPS/RAN treatment. In conclusion, RAN improved TNF-production after LPS treatment through augmented p38 activation, which seems to happen through TACE. The long term TNF-production improved PAI-1… Continue reading Ranitidine (RAN) is among the drugs connected with idiosyncratic adverse drug